Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
LMMYExousia Bio, Inc.
| Figure | LMMYExousia Bio, Inc.FY2025 · May |
|---|---|
| Revenue | $3.75K |
| Revenue, yoy | −67.4% |
| Net income | $51.40K |
| Net income, yoy | +299.2% |
| Net margin | 1,370.5% |
| Free cash flow | — |
| FCF margin | — |
| EPS, diluted | $0.00 |
Add another company.
Annual · FY2023–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed